前言：目的：探讨血脂康的非调脂功能。
Objective: to study the effect of xuezhikang treating unstable angina pectoris.
临床研究肝脂康对非酒精性脂肪肝有满意确切的临床疗效。
The clinical study has pointed out that Ganzhikang has satisfying and exact curative effect on non-alcoholic fatty liver.
目的研究益脂康对内源性和外源性家兔高血脂模型的降血脂作用。
OBJECTIVE To study the effect of Yizhikang on lowering blood lipids of endogenous and exogenous hyperlipidemia model in rabbits.
目的探讨清脂康对老年慢性缺血性心脑血管疾病患者的作用及其安全性。
Objective To evaluate the effect and safety of Qing-zhi-kang for chronic ischemia Cardio-Cerebrovascular disease in elderly.
血脂康在调脂治疗的同时，可降低FINS及提高ISI，改善胰岛素抵抗。
While regulating blood lipid, Xuezhikang could markedly decrease FINS and increase ISI, as well as relief the insulin resistance.
模型组大鼠血脂、ALT较空白对照组和肝脂康组显著增高（P＜0.01）；
The blood-fat and ALT of the rats in the model group increased markedly compared with the blank control group (P<0.01);
血脂康在调脂治疗的同时，可显著降低ET，提高NO、FMD，改善血管内皮功能。
While regulating blood lipid, Xuezhikang could markedly decrease ET and increase NO, FMD, as well as improve the endothelial function.
结果：脂调康胶囊可显著降低模型大鼠血清IL6含量。
Result:Zhitiaokang capsule can remarkably decrease IL 6 content in serum of the model of hyperlipimia rats.
目的：观察脂调康胶囊对高脂血症大鼠脑组织NO的影响。
Objective: To observe the effect of Zhitiaokang capsule on NO in Brian of hyperlipidemia rats.
目的：探讨中药肾康注射液对脂多糖诱导肾小球系膜细胞增殖的影响。
Objective: To study the effect of Shenkang injection on the proliferation of human mesangial cell induced by LPS.
动物实验研究亦表明，脂肝康胶囊有明显的降脂、保肝等作用。
The animal experiments show that Zhigankang Capsule could reduce enzyme and protect liver, etc.
结果脂调康胶囊可显著降低高脂血症患者血清IL 6含量，与脂必妥比较差异具有统计学意义（P< 0 。0 5 ）。
Results Zhitiaokang capsule remarkably decreased IL-6 content in serum of patients with hyperlipidemia, which had a statistic significance (P< 0.05)contrast to that of Zhibituo group.
结果脂调康胶囊可显著降低高脂血症患者血清IL 6含量，与脂必妥比较差异具有统计学意义（P< 0 。0 5 ）。
Results Zhitiaokang capsule remarkably decreased IL-6 content in serum of patients with hyperlipidemia, which had a statistic significance (P< 0.05)contrast to that of Zhibituo group.
应用推荐